These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38904072)

  • 41. Implementing trauma-focused cognitive behavioral therapy in Philadelphia: A 10-year evaluation.
    Last BS; Johnson C; Dallard N; Fernandez-Marcote S; Zinny A; Jackson K; Cliggitt L; Rudd BN; Mills C; Beidas RS
    Implement Res Pract; 2023; 4():26334895231199467. PubMed ID: 37790185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of Mediterranean diet and physical activity in secondary cardiovascular disease prevention: results from the UCC-SMART cohort study.
    Bonekamp NE; Visseren FLJ; van der Schouw YT; van der Meer MG; Teraa M; Ruigrok YM; Geleijnse JM; Koopal C;
    Eur J Prev Cardiol; 2024 Sep; 31(12):1460-1468. PubMed ID: 38547043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness of home-based screening of the general population for albuminuria to prevent progression of cardiovascular and kidney disease.
    Pouwels XGLV; van Mil D; Kieneker LM; Boersma C; van Etten RW; Evers-Roeten B; Heerspink HJL; Hemmelder MH; Langelaan MLP; Thelen MHM; Gansevoort RT; Koffijberg H
    EClinicalMedicine; 2024 Feb; 68():102414. PubMed ID: 38299045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness of sintilimab plus chemotherapy versus chemotherapy alone as first-line treatment of locally advanced or metastatic oesophageal squamous cell carcinoma.
    Liu L; Wang L; Chen L; Ding Y; Zhang Q; Shu Y
    Front Immunol; 2023; 14():1092385. PubMed ID: 36756110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany.
    Wirth D; Dass R; Hettle R
    BMC Health Serv Res; 2017 Mar; 17(1):182. PubMed ID: 28270207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of Pazopanib Versus Sunitinib as First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma from an Italian National Health Service Perspective.
    Capri S; Porta C; Delea TE
    Clin Ther; 2017 Mar; 39(3):567-580.e2. PubMed ID: 28189363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-Effectiveness of a PTSD Intervention Tailored for Individuals With Severe Mental Illness.
    Slade EP; Gottlieb JD; Lu W; Yanos PT; Rosenberg S; Silverstein SM; Minsky SK; Mueser KT
    Psychiatr Serv; 2017 Dec; 68(12):1225-1231. PubMed ID: 28712353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Cost-Effectiveness of Bimodal Stimulation Compared to Unilateral and Bilateral Cochlear Implant Use in Adults with Bilateral Severe to Profound Deafness.
    Theriou C; Fielden CA; Kitterick PT
    Ear Hear; 2019; 40(6):1425-1436. PubMed ID: 30998548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of a population-based AAA screening program for men over 65 years old in Iran.
    Daroudi R; Shafe O; Moosavi J; Salimi J; Bayazidi Y; Zafarghandi MR; Maleki M; Moini M; Farshidmehr P; Sadeghipour P
    Cost Eff Resour Alloc; 2021 May; 19(1):29. PubMed ID: 33985531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet-rich plasma vs. corticosteroid injections for the treatment of recalcitrant lateral epicondylitis: a cost-effectiveness Markov decision analysis.
    Klifto KM; Colbert SH; Richard MJ; Anakwenze OA; Ruch DS; Klifto CS
    J Shoulder Elbow Surg; 2022 May; 31(5):991-1004. PubMed ID: 35031496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
    Richards DA; Rhodes S; Ekers D; McMillan D; Taylor RS; Byford S; Barrett B; Finning K; Ganguli P; Warren F; Farrand P; Gilbody S; Kuyken W; O'Mahen H; Watkins E; Wright K; Reed N; Fletcher E; Hollon SD; Moore L; Backhouse A; Farrow C; Garry J; Kemp D; Plummer F; Warner F; Woodhouse R
    Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France.
    Druais S; Doutriaux A; Cognet M; Godet A; Lançon C; Levy P; Samalin L; Guillon P
    Pharmacoeconomics; 2016 Apr; 34(4):363-91. PubMed ID: 26883132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United States.
    Taieb A; Stein Gold L; Feldman SR; Dansk V; Bertranou E
    J Manag Care Spec Pharm; 2016 Jun; 22(6):654-65. PubMed ID: 27231793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trauma-focused cognitive behavioral therapy with Puerto Rican youth in a post-disaster context: Tailoring, implementation, and program evaluation outcomes.
    Orengo-Aguayo R; Dueweke AR; Nicasio A; de Arellano MA; Rivera S; Cohen JA; Mannarino AP; Stewart RW
    Child Abuse Negl; 2022 Jul; 129():105671. PubMed ID: 35580399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.
    Moore SG; Shenoy PJ; Fanucchi L; Tumeh JW; Flowers CR
    BMC Health Serv Res; 2009 Jan; 9():9. PubMed ID: 19144138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Population impact and cost-effectiveness of artificial intelligence-based diabetic retinopathy screening in people living with diabetes in Australia: a cost effectiveness analysis.
    Hu W; Joseph S; Li R; Woods E; Sun J; Shen M; Jan CL; Zhu Z; He M; Zhang L
    EClinicalMedicine; 2024 Jan; 67():102387. PubMed ID: 38314061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of the RefluxStop device for management of refractory gastroesophageal reflux disease in Switzerland.
    Harper S; Kartha M; Mealing S; Borbély YM; Zehetner J
    J Med Econ; 2024; 27(1):805-815. PubMed ID: 38820006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Pilot Randomized Clinical Trial of a Novel, Culturally Adapted, Trauma-Focused Cognitive-Behavioral Intervention for War-Related PTSD in Iraqi Women.
    Zemestani M; Mohammed AF; Ismail AA; Vujanovic AA
    Behav Ther; 2022 Jul; 53(4):656-672. PubMed ID: 35697429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reverse Total Shoulder Arthroplasty Is the Most Cost-effective Treatment Strategy for Proximal Humerus Fractures in Older Adults: A Cost-utility Analysis.
    Abdel Khalik H; Humphries B; Zoratti M; Axelrod D; Kruse C; Ristevski B; Rajaratnam K; Gardner M; Tarride JÉ; Johal H
    Clin Orthop Relat Res; 2022 Oct; 480(10):2013-2026. PubMed ID: 35507306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
    Pashayan N; Morris S; Gilbert FJ; Pharoah PDP
    JAMA Oncol; 2018 Nov; 4(11):1504-1510. PubMed ID: 29978189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.